Improved survival with adjuvant chemotherapy in locally advanced rectal cancer patients treated with preoperative chemoradiation regardless of pathologic response.

[1]  S. Wexner,et al.  Association Between Adjuvant Chemotherapy and Overall Survival in Patients With Rectal Cancer and Pathological Complete Response After Neoadjuvant Chemotherapy and Resection , 2018, JAMA oncology.

[2]  M. Choti,et al.  Association of Adjuvant Chemotherapy With Overall Survival in Patients With Rectal Cancer and Pathologic Complete Response Following Neoadjuvant Chemotherapy and Resection , 2018, JAMA oncology.

[3]  E. Winer,et al.  Perils of the Pathologic Complete Response. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  K. Attwood,et al.  Predictors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer , 2016, Annals of Surgical Oncology.

[5]  K. Milinis,et al.  Adjuvant chemotherapy for rectal cancer: Is it needed? , 2015, World journal of clinical oncology.

[6]  David D. Smith,et al.  Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. , 2015, The Lancet. Oncology.

[7]  H. Putter,et al.  Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  C. Orlandini,et al.  No benefit of adjuvant Fluorouracil Leucovorin chemotherapy after neoadjuvant chemoradiotherapy in locally advanced cancer of the rectum (LARC): Long term results of a randomized trial (I-CNR-RT). , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  P. Quirke,et al.  Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control. , 2014 .

[10]  H. Tulchinsky,et al.  Is there a role for adjuvant chemotherapy in pathological complete response rectal cancer tumors following neoadjuvant chemoradiotherapy? , 2014, Journal of Cancer Research and Clinical Oncology.

[11]  A. Haynes,et al.  Postoperative chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer: Analysis of Surveillance, Epidemiology, and End Results–Medicare data, 1998‐2007 , 2014, Cancer.

[12]  L. Collette,et al.  Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. , 2014, The Lancet. Oncology.

[13]  A. Benson,et al.  Pathological Complete Response After Neoadjuvant Therapy for Rectal Cancer and the Role of Adjuvant Therapy , 2013, Current Oncology Reports.

[14]  Sunil Krishnan,et al.  Neoadjuvant treatment response as an early response indicator for patients with rectal cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  A. Rosman,et al.  Complete Pathologic Response after Combined Modality Treatment for Rectal Cancer and Long-Term Survival: A Meta-Analysis , 2012, Annals of Surgical Oncology.

[16]  K. Bujko,et al.  Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  M. Zampino,et al.  Rectal cancer. , 2009, Critical reviews in oncology/hematology.

[18]  Quasar Collaborative Group.  Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study , 2007, The Lancet.

[19]  D. Kerr,et al.  Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study , 2007, The Lancet.

[20]  M. Piérart,et al.  Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Laurence Collette,et al.  Chemotherapy with preoperative radiotherapy in rectal cancer. , 2006, The New England journal of medicine.

[22]  L. Ellis,et al.  Clinical and Pathologic Predictors of Locoregional Recurrence, Distant Metastasis, and Overall Survival in Patients Treated With Chemoradiation and Mesorectal Excision for Rectal Cancer , 2006, American journal of clinical oncology.

[23]  J. Davila,et al.  Receipt of Recommended Therapy by Patients with Advanced Colorectal Cancer , 2006, The American Journal of Gastroenterology.

[24]  Rainer Fietkau,et al.  Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.

[25]  C. V. D. van de Velde,et al.  The role of total mesorectal excision in the management of rectal cancer. , 2002, The Surgical clinics of North America.

[26]  H. Putter,et al.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. , 2001, The New England journal of medicine.

[27]  L. Ellis,et al.  Improved Overall Survival Among Responders to Preoperative Chemoradiation for Locally Advanced Rectal Cancer , 2001, American journal of clinical oncology.

[28]  Frank E. Harrell,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2001 .

[29]  P. Grambsch,et al.  Modeling Survival Data: Extending the Cox Model , 2000 .

[30]  L Påhlman,et al.  Improved survival with preoperative radiotherapy in resectable rectal cancer. , 1997, The New England journal of medicine.

[31]  J. Niland,et al.  Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network analysis. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.